Pharmaco‐Economic Assessment of Screening Strategies for High‐Risk <scp>MASLD</scp> in Primary Care
Screening for high-risk MASLD is cost-effective according to recent guidelines. Implementing these screening strategies in primary care should be considered.
Authors
- James M. Paik (ORCID: https://orcid.org/0000-0003-2294-323X)
- Linda Henry (ORCID: https://orcid.org/0000-0002-7833-6124)
- Maria Stepanova (ORCID: https://orcid.org/0000-0002-8385-4321)
- Zobair M. Younossi (ORCID: https://orcid.org/0000-0001-9313-577X)
- Fatema Nader
Institutions
- Inova Health System (US)
- Center for Outcomes Research in Liver Diseases (US)
Publication Details
- Journal
- Liver International
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1111/liv.16119
- Citations
- 27
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 10.44
Funders
- Inova Health System
- Siemens Healthineers